Related Experiment Videos
[Cytokines in systemic lupus erythematosus]
E Robak1, A Sysa-Jedrzejowska, T Robak
1Katedry i Kliniki Dermatologii i Wenerologii Akademii Medycznej w Lodzi.
Przeglad Lekarski
|January 1, 1996
Summary
Systemic lupus erythematosus (SLE) involves B cell hyperactivity. This review highlights key cytokines like IL-1, IL-6, and IFN-gamma, crucial for understanding lupus pathogenesis and immune dysregulation.
Area of Science:
- Immunology
- Pathophysiology
Context:
- Systemic lupus erythematosus (SLE) is an autoimmune disease marked by B cell hyperactivity, autoantibody generation, and immune complex deposition.
- Immune dysregulation in SLE is increasingly linked to the role of cytokines.
Purpose:
- To review the role of specific cytokines in the pathogenesis of systemic lupus erythematosus (SLE).
Summary:
- Elevated serum levels of cytokines, including interleukin-1 (IL-1), IL-2, IL-6, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha), correlate with SLE disease activity and symptoms.
- Aberrant constitutive expression and in vitro induction of cytokines are observed in SLE.
- Local pathogenic effects are suggested by the presence of IL-1, IL-6, and IFN-gamma in affected kidneys.
- IFN-gamma, IL-6, and IL-1 modulate spontaneous immunoglobulin G (IgG) production by SLE mononuclear cells.
Impact:
- This review provides insights into the cytokine-mediated mechanisms underlying SLE pathogenesis.
- Further elucidation of these cytokine roles will advance understanding and potentially therapeutic strategies for lupus.